# Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy

> **NCT05918718** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 150 (estimated)

## Conditions studied

- Ectopic Pregnancy

## Interventions

- **DRUG:** Letrozole
- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT05918718
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-20
- **Primary completion:** 2024-05-20
- **Final completion:** 2024-12-20
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05918718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05918718, "Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05918718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*